Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.

[1]  F. Simons,et al.  Skin concentrations of H1-receptor antagonists. , 2001, The Journal of allergy and clinical immunology.

[2]  E. Juniper,et al.  Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  H. Nelson,et al.  Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  P. Howarth,et al.  Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. , 1999, The Journal of allergy and clinical immunology.

[5]  A. Kaplan,et al.  A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. , 1999, The Journal of allergy and clinical immunology.

[6]  T. Casale,et al.  Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. , 1999, Allergy and asthma proceedings.

[7]  C. Falliers,et al.  Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies. , 1998, Allergy and asthma proceedings.

[8]  K. Simons,et al.  Peripheral H1-blockade effect of fexofenadine. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  D. Bernstein,et al.  Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  E. Monroe,et al.  Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines. , 1997, The Journal of allergy and clinical immunology.

[11]  S. Holgate,et al.  The comparative actions and adverse effect profile of single doses of H1-receptor antihistamines in the airways and skin of subjects with asthma. , 1993, The Journal of allergy and clinical immunology.

[12]  K. Simons,et al.  A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. , 1990, The Journal of allergy and clinical immunology.

[13]  K. Simons,et al.  Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly. , 1990, The Journal of allergy and clinical immunology.

[14]  S. Rastogi,et al.  A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results. , 1982, The Journal of allergy and clinical immunology.

[15]  E. Middleton,et al.  Allergy, principles and practice , 1978 .